Syntracts | $5,300,000 | (Oct 24, 2025)
GradBridge | $20,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Certified by Founder
Lodge
Clarametyx Biosciences
start up
United States
- Columbus, Ohio
- 08/01/2024
- Series A
- $33,000,000
Clarametyx Biosciences Inc. is a clinical stage biotechnology company developing immune-enabling biologic therapies to fight life-threatening infections. Our novel technology platform targets the protective barrier around bacteria, known as biofilms.
- Industry Biotechnology Research
- Website https://clarametyx.com/
- LinkedIn https://www.linkedin.com/company/clarametyx-biosciences/about/
Related People
David V. RichardsFounder
United States -
Columbus, Ohio
Life sciences executive and entrepreneur with a passion for building transformative science into compelling companies. Focus on high patient need categories that hold the potential for broad impact on national and global health, with a personal interest in infectious disease, neurocognitive and genetic disorders.
CipherOwl | $15,000,000 | (Oct 24, 2025)
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
Vermeer | $10,000,000 | (Oct 24, 2025)
GammaTime | $14,000,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Apriority Financial, Inc. | $2,300,000 | (Oct 24, 2025)
OneAM | $4,700,000 | (Oct 24, 2025)
🌱 Rightcharge | $2,131,920 | (Oct 24, 2025)
Tensormesh | $4,500,000 | (Oct 24, 2025)